Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T10:30:50.176Z Has data issue: false hasContentIssue false
  • English
  • Français

Your cheatin’ heart

Published online by Cambridge University Press:  21 May 2015

Bjug Borgundvaag
Bjug Borgundvaag*
Affiliation:
University of Toronto, Toronto, Ont.; Research, Division of Emergency Services, Mount Sinai Hospital, Toronto, Ont.
*
University of Toronto, Division of Emergency Services, Mount Sinai Hospital, 600 University Ave., Rm. 206, Toronto ON M5G 1X5; 416 586-4800 x2144, fax 416 586-4719 [email protected]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary • Commentaire
Information
Canadian Journal of Emergency Medicine , Volume 5 , Issue 2 , March 2003 , pp. 124 - 126
Copyright
Copyright © Canadian Association of Emergency Physicians 2003

References

1.Katis, PG., Dias, SM.Owner of a broken heart? CJEM 2003;5(2): 123;139–40.Google Scholar
2.Naylor, CD., Slaughter, PMP, Institute for Clinical Evaluative Sciences in Ontario, Heart and Stroke Foundation of Ontario. Cardiovascular health & services in Ontario: an ICES atlas. Toronto (ON): ICES; 1999.Google Scholar
3.Kleiman, NS., White, HD., Ohman, EM., Ross, AM., Woodlief, LH., Califf, RM., et al. Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Circulation 1994;90(6):2658–65.Google Scholar
4.Savonitto, S., Ardissino, D., Granger, CB., Morando, G., Prando, MD., Mafrici, A., et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999;281:707–13.CrossRefGoogle ScholarPubMed
5.Topol, EJ.Current and emerging anti-thrombotic therapies for acute coronary syndromes. J Inv Card 1998;10(suppl D):2D-7D.Google Scholar
6.Cannon, CP., Gibson, CM., Lambrew, CT., Shoultz, DA., Levy, D., French, WJ., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941–7.CrossRefGoogle ScholarPubMed
7.Bhatt, DL.The importance of time to treatment on outcomes: a postrandomization analysis from PURSUIT. Circ Suppl 1998;I:I–560.Google Scholar
8.Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Lancet 1994;343:311–22.Google Scholar
9.Collinson, PO.Troponin T or troponin I or CK-MB (or none?). Eur Heart J 1998;19(suppl N):N16–24.Google ScholarPubMed
10.Hamm, CW, Ravkilde, J, Gerhardt, W, Jorgensen, P, Peheim, E, Ljungdahl, L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146–50.Google Scholar
11.Lindahl, B, Venge, P, Wallentin, L.Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996;93:1651–7.Google Scholar
12.Ohman, EM, Armstrong, PW, Christenson, RH, Granger, CB, Katus, HA, Hamm, CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996;335:1333–41.CrossRefGoogle ScholarPubMed
13.Ravkilde, J, Nissen, H, Horder, M, Thygesen, K.Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol 1995;25:574–81.Google Scholar
14.Aviles, RJ, Wright, RS, Aviles, JM, McDonald, F, Ballman, K, Harker-Murray, A, et al. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin I levels. Am J Cardiol 2002;90:875–8.Google Scholar
15.Lindahl, B, Toss, H, Siegbahn, A, Venge, P, Wallentin, L.Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000;343:1139–47.Google Scholar
16.Heeschen, C, van Den Brand, MJ, Hamm, CW, Simoons, ML.Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation 1999;100:1509–14.Google Scholar
17.Myocardial infarction redefined — a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502–13.Google Scholar
18.Hamm, CW, Heeschen, C, Goldmann, B, Vahanian, A, Adgey, J, Miguel, CM, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999;340:1623–9.Google Scholar
19.Heeschen, C, Hamm, CW, Goldmann, B, Deu, A, Langenbrink, L, White, HD.Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet 1999;354:1757–62.Google Scholar
20.Morrow, DA, Cannon, CP, Rifai, N, Frey, MJ, Vicari, R, Lakkis, N, et al; TACTICS-TIMI 18 investigators. Ability of minor elevation of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286(19):2405–12.CrossRefGoogle Scholar
21.Simoons, ML.Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 2001;357:1915–24.Google Scholar
22.Lauer, B, Niederau, C, Kuhl, U, Schannwell, M, Pauschinger, M, Strauer, BE, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997;30:1354–9.CrossRefGoogle ScholarPubMed
23.Perna, ER, Macin, SM, Parras, JI, Pantich, R, Farias, EF, Badaracco, JR, et al. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am Heart J 2002;143:814–20.CrossRefGoogle Scholar
24.Ishii, J, Nomura, M, Nakamura, Y, Naruse, H, Mori, Y, Ishikawa, T, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J of Cardiol 2002;89:691–5.CrossRefGoogle ScholarPubMed
25.Musso, P, Cox, I, Vidano, E, Zambon, D, Panteghini, M.Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance. Clin Biochem 1999;32:125–30.CrossRefGoogle ScholarPubMed
26.Dierkes, J, Domrose, U, Westphal, S, Ambrosch, A, Bosselmann, HP, Neumann, KH, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000;102:1964–9.CrossRefGoogle ScholarPubMed
27.Konstantinides, S, Geibel, A, Olschewski, M, Kasper, W, Hruska, N, Jackle, S, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002;106:1263–8.Google Scholar
28.Giannitsis, E, Muller-Bardorff, M, Kurowski, V, Weidtmann, B, Wiegand, U, Kampmann, M, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211–7.CrossRefGoogle ScholarPubMed
29.Khan, IA, Tun, A, Wattanasauwan, N, Win, MT, Hla, TA, Hussain, A, et al. Elevation of serum cardiac troponin I in noncardiac and cardiac diseases other than acute coronary syndromes. Am J Emerg Med 1999;17:225–9.Google Scholar
30.Ng, SM, Krishnaswamy, P, Morrisey, R, Clopton, P, Fitzgerald, R, Maisel, AS.Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J of Cardiol 2001;87:994–9; A4.Google Scholar
31.Kratz, A, Lewandrowski, KB, Januzzi, JL, Flood, JG, Lee-Lewandrowski, E.Comparison of cardiac marker concentrations in healthy blood donors and hospital patients without acute coronary syndrome. Am J Cardiol 2002;90:177–8.CrossRefGoogle ScholarPubMed
32.Smith, KJ, Theal, M, Mulji, A.Pericarditis presenting and treated as an acute anteroseptal myocardial infarction. Can J of Cardiol 2001;17:815–7.Google ScholarPubMed
33.Youssef, G, Khouzam, S, Sprung, J, Bourke, DL.Regional pericarditis mimicking myocardial infarction. Anesthesiology 2001;95:261–4.Google Scholar
34.Bonnefoy, E, Godon, P, Kirkorian, G, Fatemi, M, Chevalier, P, Touboul, P.Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J 2000;21:832–6.Google Scholar
35.Brandt, RR, Filzmaier, K, Hanrath, P.Circulating cardiac troponin I in acute pericarditis. Am J Cardiol 2001;87:1326–8.CrossRefGoogle ScholarPubMed